Table 2.
SVM analysis accurately predicts future disease severity in RA patients using ERA 19-gene expression profiles as the training set.
| Training set input | |||
|---|---|---|---|
| Patient sample | SVM input | 19-gene class | Clinical class |
| ERA1 | Severe | Severe | Severe |
| ERA2 | Mild | Mild | Mild |
| ERA3 | Mild | Mild | Mild |
| ERA4 | Mild | Mild | Mild |
| ERA6 | Severe | Severe | Severe |
| ERA8 | Mild | Mild | Mild |
| ERA9 | Mild | Mild | Mild |
| ERA12 | Severe | Severe | Severe |
| ERA13 | Severe | Severe | Severe |
| ERA14 | Severe | Severe | Severe |
| ERA15 | Mild | Mild | Mild |
| ERA16 | Mild | Mild | Mild |
| ERA20 | Mild | Mild | Mild |
| ERA21 | Severe | Severe | Severe |
| ERA22 | Severe | Severe | Severe |
| ERA24 | Mild | Mild | Mild |
| ERA25 | Severe | Severe | Severe |
| Classified set output | |||
| Patient sample | SVM input | SVM output | Clinical class |
| RA1 | Unassigned | Mild | Severe |
| RA2 | Unassigned | Severe | Severe |
| RA3 | Unassigned | Mild | Mild |
| RA4 | Unassigned | Severe | Severe |
| RA5 | Unassigned | Severe | Severe |
| RA6 | Unassigned | Severe | Severe |
| RA7 | Unassigned | Mild | Mild |
| RA8 | Unassigned | Mild | Mild |
| RA9 | Unassigned | Mild | Mild |
Details of the analysis are described in the text.